Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FDG-PET/CT Versus Conventional CT for Response Monitoring in Metastatic Breast Cancer: A Multicenter Randomized Clinical Trial (MONITOR-RCT)

NCT06877949 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT06877949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06877949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FDG-PET/CT Versus Conventional CT for Response Monitoring in Metastatic Breast Cancer: A Multicenter Randomized Clinical Trial (MONITOR-RCT)
Lead sponsor
Odense University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
April 2, 2025
Completion date
April 30, 2029
Enrollment
420 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer, response monitoring